<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02711839</url>
  </required_header>
  <id_info>
    <org_study_id>201505027</org_study_id>
    <nct_id>NCT02711839</nct_id>
  </id_info>
  <brief_title>Evaluation of White Sweet Potato Tube Feeding Formula on Type 2 Diabetic Residents in Long-term Care Institutions</brief_title>
  <official_title>Office of Human Research, Taipei Medical University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to response the increasing of aging population cause losing ability that need
      long-care needs, the project entitled &quot;10-year long-term care program&quot; from Executive Yuan in
      2007 is carried out to assist economically disadvantaged and disabled elderly to acquire
      daily nutrition. Therefore, the long-term care resident's nutritional status got more
      attention than before. Out of control in blood glucose will not only increase bed sores and
      urinary tract infection in tube feeding residents but also rise medical expenditures. The
      nutritional status of long-term care institutions, anyang homes and nursing home are
      generally bad in nutrition management due to high cost of nutritional supplements from
      foreign imports that cause the burden of families. In this study, we will recruit diabetic
      subjects that divide into white sweet potato group (experimental group) and commercial
      formula group (control group) by using randomized, parallel and open clinical study through
      tube feeding in sixty days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will be evaluated the blood sugar and clinical nutrition assessment such as
      postural measurement, urine test and blood biomarker examination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c After Intervention</measure>
    <time_frame>60 days</time_frame>
    <description>HbA1c value after 60 days intervention in both groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Albumin After Intervention</measure>
    <time_frame>60 days</time_frame>
    <description>Albumin value after 60 days intervention in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose After Intervention</measure>
    <time_frame>60 days</time_frame>
    <description>Glucose value after 60 days intervention in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol After Intervention</measure>
    <time_frame>60 days</time_frame>
    <description>Total cholesterol value after 60 days intervention in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglyceride After Intervention</measure>
    <time_frame>60 days</time_frame>
    <description>Triglyceride value after 60 days intervention in both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Commercial diabetic formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>White sweet potato formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Commercial diabetic formula</intervention_name>
    <description>The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>diabetic formula</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>White sweet potato formula</intervention_name>
    <description>The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
    <arm_group_label>Treatment Group</arm_group_label>
    <other_name>White sweet potato</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Long-term stability nasogastric or gastrostomy-fed person.

          -  The physician diagnosed as diabetic and regular use of hypoglycemic drugs.

        Exclusion Criteria:

          -  Psychosis or depression.

          -  Hba1c&gt; 8.5%.

          -  High taking nutritional supplements or steroids drugs.

          -  Have undergone abdominal surgery caused by intestinal sticky.

          -  Suffering from cancer, ulcers, respiratory infections and other diseases.

          -  Currently receiving central venous nutrition therapy or intravenous nutrition therapy.

          -  Liver dysfunction (ALT ≧ 100 U / L), renal insufficiency (creatinine ≧ 3mg / dl),
             heart failure (NYFc II above), moderate anemia (hemoglobin &lt;9 g / dl).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chih-Han Lin, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Office of Human Research, Taipei Medical University</affiliation>
  </overall_official>
  <reference>
    <citation>Ooi CP, Loke SC. Sweet potato for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013 Sep 3;(9):CD009128. doi: 10.1002/14651858.CD009128.pub3. Review.</citation>
    <PMID>24000051</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>November 17, 2015</study_first_submitted>
  <study_first_submitted_qc>March 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2016</study_first_posted>
  <results_first_submitted>January 24, 2018</results_first_submitted>
  <results_first_submitted_qc>April 9, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 1, 2019</results_first_posted>
  <last_update_submitted>April 9, 2019</last_update_submitted>
  <last_update_submitted_qc>April 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
        </group>
        <group group_id="P2">
          <title>Treatment Group</title>
          <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
        </group>
        <group group_id="B2">
          <title>Treatment Group</title>
          <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.7" spread="5.7"/>
                    <measurement group_id="B2" value="68.9" spread="8.8"/>
                    <measurement group_id="B3" value="71.8" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>HbA1c After Intervention</title>
        <description>HbA1c value after 60 days intervention in both groups</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
        </group_list>
        <measure>
          <title>HbA1c After Intervention</title>
          <description>HbA1c value after 60 days intervention in both groups</description>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="1.1"/>
                    <measurement group_id="O2" value="6.4" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Albumin After Intervention</title>
        <description>Albumin value after 60 days intervention in both groups</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
        </group_list>
        <measure>
          <title>Albumin After Intervention</title>
          <description>Albumin value after 60 days intervention in both groups</description>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="0.1"/>
                    <measurement group_id="O2" value="3.6" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glucose After Intervention</title>
        <description>Glucose value after 60 days intervention in both groups</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose After Intervention</title>
          <description>Glucose value after 60 days intervention in both groups</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126.7" spread="38.9"/>
                    <measurement group_id="O2" value="131.0" spread="45.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Cholesterol After Intervention</title>
        <description>Total cholesterol value after 60 days intervention in both groups</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol After Intervention</title>
          <description>Total cholesterol value after 60 days intervention in both groups</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="180.0" spread="53.6"/>
                    <measurement group_id="O2" value="150.1" spread="25.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglyceride After Intervention</title>
        <description>Triglyceride value after 60 days intervention in both groups</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group</title>
            <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
          </group>
        </group_list>
        <measure>
          <title>Triglyceride After Intervention</title>
          <description>Triglyceride value after 60 days intervention in both groups</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="214.3" spread="112.2"/>
                    <measurement group_id="O2" value="145.4" spread="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse event data were collected from the participants during intervention and assessed after 6 months.</time_frame>
      <desc>No adverse event was happened in participants.</desc>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>Commercial diabetic formula
Commercial diabetic formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
        </group>
        <group group_id="E2">
          <title>Treatment Group</title>
          <description>White sweet potato formula
White sweet potato formula: The formula were supplied 1500~1800 kcal daily depend on the patient's individual situation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small experimental sample size and trial duration that may cause impose an obstacle in the detection of significant changes of the study measure.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Sing-Chung Li</name_or_title>
      <organization>Taipei Medical University</organization>
      <phone>886-2-27361661 ext 6560</phone>
      <email>sinchung@tmu.edu.tw</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

